VanEck Biotech ETF
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All BBH news ›VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth?
VanEck Biotech ETF (BBH -0.74%) offers concentrated exposure to the high-growth biotechnology industry, while Invesco S&P 500 Equal Weight Health Care ETF (RSPH -0.80%) provides equal-weighted access across the broader healthcare sector.…
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?
The VanEck Biotech ETF (BBH +0.68%) offers a concentrated play on industry giants, while the State Street SPDR S&P Biotech ETF (XBI -0.30%) provides broad exposure across the biotechnology sector. Investors seeking biotechnology exposure…
Biotech ETF (BBH) Hits New 52-Week High
For investors seeking momentum, VanEck Biotech ETF BBH is probably on the radar. The fund just hit a 52-week high and has risen 41.1% from its 52-week low price of $176.30/share. But are there more gains in store for this ETF? Let’s take a…
More from 1 other outlet
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
The Fidelity MSCI Health Care Index ETF offers a lower expense ratio than the Invesco Biotechnology & Genome ETF. The Invesco Biotechnology & Genome ETF focuses on a concentrated basket of biotech stocks, whereas the Fidelity MSCI Health…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- fool.com2
- theglobeandmail.com2
- themarketsdaily.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.